Sunscreen sits at the intersection of longevity science, regulatory constraint, and daily consumer behavior, making it one of the few categories with both structural demand and underleveraged value creation. While usage has normalized, technological differentiation and compliance economics remain underdeveloped relative to its strategic importance. The next phase will be defined not by higher SPF claims but by how effectively brands translate photoprotection into measurable, science-led skin longevity equity.